1. Gómez M, Otero W, Caminos JE. Gastric cancer in young patients in Colombia. Rev Col Gastroenterol. 2012 Jul-sept; 27(3):166-72.
2. Subbiah V, Varadhachary G, Herzog CE, Huh WW. Gastric adenocarcinoma in children and adolescents. Pediatr Blood Cancer. 2011 Sept; 57(3):524-7. doi: 10.1002/pbc.23051.
3. Schwartz MG, Sgaglione NA. Gastric carcinoma in the young: overview of the literature. Mt Sinai J Med N Y. 1984 Dec;51(6):720-3.
4. Goldthorn JF, Canizaro PC. Gastrointestinal malignancies in infancy, childhood, and adolescence. Surg Clin North Am. 1986 Aug;66(4):845-61. doi: 10.1016/s0039-6109(16)43996-4.
5. Harting MT, Blakely ML, Herzog CE, Lally KP, Ajani JA, Andrassy RJ. Treatment issues in pediatric gastric adenocarcinoma. J Pediatr Surg. 2004 Aug;39(8):e8-10. doi: 10.1016/j.jpedsurg.2004.04.043.
6. Huang J-Q, Hunt RH. The evolving epidemiology of Helicobacter pylori infection and gastric cancer. Can J Gastroenterol J Can Gastroenterol. 2003 Jun;17 Suppl B:18B-20B. doi: 10.1155/2003/692808.
7. Nardone G. Review article: molecular basis of gastric carcinogenesis. Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:75-81. doi: 10.1046/j.1365-2036.17.s2.10.x.
8. Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surg Today. 2011 Jan;41(1):24-38. doi: 10.1007/s00595-010-4370-5.
9. Lin C-H, Lin W-C, Lai I-H, Wu S-F, Wu K-H, Chen A-C. Pediatric gastric cancer presenting with massive ascites. World J Gastroenterol. 2015 Mar 21; 21(11):3409-13. doi: 10.3748/wjg.v21.i11.3409.
10. Sasaki H, Sasano H, Ohi R, Imaizumi M, Shineha R, Nakamura M, et al. Adenocarcinoma at the esophageal gastric junction arising in an 11-year-old girl. Pathol Int. 1999 Dec;49(12):1109-13. doi: 10.1046/j.1440-1827.1999.00993.x.
11. Lu J, Huang C, Zheng C, Li P, Xie J, Wang J, et al. [Gastric carcinoma in a 12-year-old girl: a case report and literature review]. Zhonghua Wei Chang Wai Ke Za Zhi Chin J Gastrointest Surg. 2012 Sept;15(9):967-70. PMID: 22990936
12. Zheng N, Xiao XM, Dong KR, Chen L, Ma YY, Li K. Primary gastric tumors in infants and children: 15 cases of 20-year report. J Cancer Res Clin Oncol. 2016 May;142(5):1061-7. doi: https://doi.org/10.1007/s00432-015-2103-2
13. Olivares-Gutiérrez, M B-L NA. Adenocarcinoma gástrico en adolescente de 17 años de edad. ARCHIVOS DE MEDICINA. 2015;11(34):1-6.
14. Corso G, Marrelli D, Roviello F. Familial gastric cancer and germline mutations of E-cadherin. Ann Ital Chir. 2012 May-Jun;83(3):177-82. PMID: 22595728
15. Dong LL, Liu L, Ma CH, Li JS, Du C, Xu S, et al. E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK/ERK pathway. Acta Pharmacol Sin. 2012;33(6):817–22.). doi: 10.1038/aps.2012.30.
16. Kim MS, Chung NG, Kang MR, Yoo NJ, Lee SH. Genetic and expressional alterations of CHD genes in gastric and colorectal cancers. Histopathology. 2011;58(5):660–8. doi.org/10.1111/j.1365-2559.2011.03819.x
17. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med. 2001Jun;344(25):1904-9. doi: 10.1056/NEJM200106213442504.
18. Kaurah P, Huntsman DG. Adam M, Ardinger H, Pagon R, Wallace E, et al. Hereditary Diffuse Gastric Cancer. GeneReviews®. [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2020. 2002 Nov 4 [Updated 2018 Mar 22]. PMID: 20301318
19. Olivier M, Hollstein M, Hainaut P. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008. doi: 10.1101/cshperspect.a001008.
20. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet. 2001 Apr;10(7):721-33. doi: 10.1093/hmg/10.7.721.
21. Rúa KA, Jiménez L.F, Ahumada E, Ceballos H, Muñetón C.M. Análisis genético en APC, KRAS y TP53 en pacientes con cáncer de estómago y colon. Revista de gastroenterología de méxico. 2014;79(2):79-89. doi.org/10.1016/j.rgmx.2014.05.001